Science & tech

Cannabis Shows Promise in Yet Another Type of Cancer: HCC Liver Tumors

Published on November 4, 2015 · Last updated September 23, 2022

Over the last couple years, we’ve watched researchers unearth new evidence supporting marijuana’s therapeutic potential in various types of cancer, some of which include bladder cancer, glioma, leukemia, and breast cancer. Now researchers from China’s Guangzhou Medical University suspect that cannabis compounds could offer future treatments for hepatocellular carcinoma (HCC), the most common type of liver cancer.

Researchers targeted affected cells with a synthetic cannabis-like compound and noticed inhibited growth of cancerous cells. Cannabinoid receptor agonists appeared to disrupt cell cycle regulation, leading scientists to believe that cannabinoid therapy could be the next possible treatment frontier for this deadly cancer.

“Hepatocellular carcinoma (HCC) is the leading cause of cancer deaths worldwide, however, only limited therapeutic treatments are available,” the study’s authors wrote. But questions still remain, such as how would results change with phytocannabinoids sourced from the plant itself? What results would we see in human trials?

Needless to say, this discovery adds to a growing body of research building a compelling case for cannabis as a target for cancer medicine. The U.S. government’s National Cancer Institute quietly acknowledged marijuana’s role in killing cancer cells, and the American Cancer Society has called for rescheduling of cannabis to better facilitate its research. Even the National Institute of Drug Abuse (NIDA) admitted that “marijuana can kill certain cancer cells and reduce the size of others.” Yes, NIDA, the federal research organization that has long touted the dangers of cannabis based on studies fixated on abuse.

So keep the studies coming, scientists of the world. We eagerly await your life-changing discoveries.

#JustSayKnow

Shop highly rated dispensaries near you

Showing you dispensaries near
See all dispensaries
Bailey Rahn
Bailey Rahn
Bailey is a senior content manager at Leafly, specializing in strains and health. She's spent 7+ years researching cannabis products, spreading patients’ stories, and exploring healthy ways of integrating cannabis into daily life.
View Bailey Rahn's articles
Get good reads, local deals, and strain spotlights delivered right to your inbox.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.



Stay In Touch

Receive updates on new products, special offers, and industry news.

By providing us with your email address, you agree to Leafly's Terms of Service and Privacy Policy.

Leafly mobile app
Get high for less.
Download the Leafly app.
Download Leafly: Marijuana Reviews on the App Store
Download Leafly Marijuana Reviews on Google Play




* Statements made on this website have not been evaluated by the U.S. Food and Drug Administration. These products are not intended to diagnose, treat, cure or prevent any disease. Information provided by this website or this company is not a substitute for individual medical advice.


© 2024 Leafly, LLC
Leafly and the Leafly logo are registered trademarks of Leafly, LLC. All Rights Reserved.